Early detection and treatment that improves survival chances is a paradigm in cancer treatment. Cancer, especially prostate cancer, has impacted more to men than women as their percentage was much lesser than men. Our study investigated that, Prostate cancer is the 2nd most common cancer in men across developed countries to date. At the same time incidences rate has also surged over time. According to the Renub Research report, Global Prostate Cancer Diagnostics Market will be US$ 7.5 Billion by 2027.